InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (3 ops.)
Explore the detailed record of transactions filed by Kelly Thomas Patrick, Chief Financial Officer. Director active across 1 companies, notably Deciphera Pharmaceuticals, Inc.. Cumulatively, 7 disclosures have been recorded. Total volume traded: €40k. The latest transaction was disclosed on 16 June 2022 (Cession). Regulator: SEC (Form 4). All data is free.
Declarations7 total
€18,0211,768 shares@ €10.192645.3% of flow
Common Stock
SEC:0001209191-22-038426:0·
€10,9011,368 shares@ €7.968827.4% of flow
Common Stock
SEC:0001209191-22-011357:0·
€10,9011,368 shares@ €7.9688100.0% of flow
Common Stock
SEC:0001209191-22-011357·
020,500 shares0
Common Stock
SEC:0001209191-22-004078:0·
020,500 shares0
Common Stock
SEC:0001209191-22-004078·
011,100 shares0
Common Stock
SEC:0001209191-21-070250·
011,100 shares0
Common Stock
SEC:0001209191-21-070250:0·
7 of 7 declarations
About Kelly Thomas Patrick
Kelly Thomas Patrick is the Chief Financial Officer of Deciphera Pharmaceuticals, Inc. In this role, he is responsible for managing the company's finances, including financial planning, risk management, and investment strategy. His role is crucial in ensuring the financial health of the organization and supporting its growth. Kelly Thomas Patrick works closely with other executives to align financial objectives with the overall strategy of the company.
